BRIEF published on 04/08/2026 at 22:05, 6 months ago Inventiva Submits 2025 Financial Reports to AMF and SEC Inventiva 2025 Financial Reports MASH Treatments Biopharmaceutical Developments AMF And SEC Filings
PRESS RELEASE published on 04/08/2026 at 22:00, 6 months ago Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-F Inventiva files 2025 Universal Registration Document and Annual Report on Form 20-F with AMF and SEC, focusing on MASH therapies Biopharmaceutical 2025 Filing Inventiva MASH
BRIEF published on 04/02/2026 at 15:55, 6 months 7 days ago JP Morgan Chase & Co. crosses the thresholds for participation in INVENTIVA Voting Rights Threshold Crossing JP Morgan Inventiva Equity Swap
BRIEF published on 03/30/2026 at 22:16, 6 months 9 days ago Inventiva Announces 2025 Financial Results and Business Update Public Offering Cash Reserves Inventiva Lanifibranor 2025 Financial Results
PRESS RELEASE published on 03/30/2026 at 22:11, 6 months 9 days ago Inventiva reports 2025 full year results and provides a business update Inventiva reports 2025 full year results with €4.5 million revenues, provides business update on strategic pipeline, clinical trials, and financial performance Financial Performance Business Update Clinical Trials Inventiva 2025 Results
BRIEF published on 03/23/2026 at 22:05, 6 months 16 days ago Inventiva Announces Schedule for 2025 Financial Results Financial Results Conference Call Biopharmaceutical Inventiva MASH
BRIEF published on 03/23/2026 at 22:05, 6 months 16 days ago Inventiva announces its 2025 annual financial results Financial Results Conference Call Investors Steatohepatitis Oral Therapy
PRESS RELEASE published on 03/23/2026 at 22:00, 6 months 16 days ago Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results Inventiva to release 2025 full-year financial results on March 30, 2026, followed by a conference call on March 31, 2026. Details on the company's website Financial Results Conference Call Biopharmaceutical Inventiva Therapy
BRIEF published on 03/23/2026 at 09:51, 6 months 17 days ago JP Morgan Chase & Co. crosses ownership thresholds in INVENTIVA Actions Participation Threshold Crossing JP Morgan Inventiva
BRIEF published on 03/23/2026 at 09:50, 6 months 17 days ago Threshold crossings at INVENTIVA Shareholders Voting Rights Inventiva Threshold Crossings Shareholders' Agreement
Published on 10/09/2026 at 14:00, 5 hours 49 minutes ago Stillwater Critical Minerals Upgrades to OTCQX Best Market, Expanding U.S. Market Presence
Published on 10/09/2026 at 14:00, 5 hours 49 minutes ago Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer
Published on 10/09/2026 at 13:23, 6 hours 26 minutes ago SLAM Exploration Announces Leadership Transition and Appointment of Jimmy Gravel as President and CEO
Published on 10/09/2026 at 13:00, 6 hours 49 minutes ago Horizon Aircraft Reports Fiscal 2027 First Quarter Results and Advances Full-Scale Cavorite X7 Development
Published on 10/09/2026 at 13:00, 6 hours 49 minutes ago Nepra Foods Launches Flagship PROPASTA Brand on Amazon
Published on 10/09/2026 at 19:22, 26 minutes ago EQS-Adhoc: elumeo SE switches financial reporting to comply with the German Commercial Code (HGB) and refines forecast for 2026
Published on 10/09/2026 at 18:00, 1 hour 48 minutes ago ARVERNE GROUP: Arverne reaches a major milestone: Europe recognizes the Lithium de France Project as a pillar of its industrial sovereignty
Published on 10/09/2026 at 18:00, 1 hour 48 minutes ago Private Equity Holding AG: Net Asset Value as of September 30, 2026
Published on 10/09/2026 at 17:15, 2 hours 33 minutes ago OPPO Find X10 Pro Max to Debut Globally with MediaTek’s 2nm Flagship Dimensity 9600 Pro
Published on 10/09/2026 at 19:27, 21 minutes ago Disclosure of transactions in own shares from October 1 to October 9, 2026
Published on 10/08/2026 at 18:30, 1 day 1 hour ago Cegedim: Release of its 2026 Interim Financial Report
Published on 10/08/2026 at 18:00, 1 day 1 hour ago Launch of LINK, the next generation of THIN: Clinityx’s first European Health Data Warehouse, approved by the French Data Protection Authority for 10 years
Published on 10/08/2026 at 17:45, 1 day 2 hours ago Carrefour announces a real estate sale and leaseback transaction involving 35 stores in France and Spain
